| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | 259,894 | 18,611,000 | 3.57% | ||
| 2 | BRISTOL MYERS SQUIBB CO | 281,000 | 16,422,000 | 3.15% | ||
| 3 | ALLERGAN PLC | 76,000 | 15,961,000 | 3.06% | ||
| 4 | LILLY ELI & CO | 215,000 | 15,813,000 | 3.03% | ||
| 5 | MEDTRONIC PLC | 215,240 | 15,332,000 | 2.94% | ||
| 6 | INCYTE | 140,000 | 14,038,000 | 2.69% | ||
| 7 | TEVA PHARMACEUTICAL INDS LTD | 360,000 | 13,050,000 | 2.50% | ||
| 8 | EXELIXIS INC | 830,000 | 12,375,000 | 2.37% | ||
| 9 | UNITEDHEALTH GROUP INC | 75,017 | 12,006,000 | 2.30% | ||
| 10 | ABIOMED INC | 102,700 | 11,572,000 | 2.22% | ||
| 11 | HORIZON PHARMA PLC | 700,000 | 11,326,000 | 2.17% | ||
| 12 | ALEXION PHARMACEUTIC | 91,702 | 11,220,000 | 2.15% | ||
| 13 | ARIAD PHARMACEUTICALS INC | 895,000 | 11,134,000 | 2.13% | ||
| 14 | CVS HEALTH CORP | 140,000 | 11,047,000 | 2.12% | ||
| 15 | PFIZER INC | 333,300 | 10,826,000 | 2.08% | ||
| 16 | CELGENE CORP | 93,000 | 10,765,000 | 2.06% | ||
| 17 | BIOGEN INC | 36,000 | 10,209,000 | 1.96% | ||
| 18 | REGENERON PHARMACEUTICALS | 26,500 | 9,728,000 | 1.86% | ||
| 19 | AMGEN INC | 65,000 | 9,504,000 | 1.82% | ||
| 20 | CIGNA CORPORATION | 69,000 | 9,204,000 | 1.76% | ||
| 21 | CENTENE CORP DEL | 150,000 | 8,477,000 | 1.63% | ||
| 22 | ANTHEM INC | 58,257 | 8,376,000 | 1.61% | ||
| 23 | ZIMMER BIOMET HLDGS INC | 80,000 | 8,256,000 | 1.58% | ||
| 24 | HUMANA | 40,000 | 8,161,000 | 1.56% | ||
| 25 | HCA HOLDINGS INC | 104,707 | 7,750,000 | 1.49% | ||
| 26 | AETNA INC NEW | 62,000 | 7,689,000 | 1.47% | ||
| 27 | EXPRESS SCRIPTS HLDG CO | 111,000 | 7,636,000 | 1.46% | ||
| 28 | ABBVIE INC | 115,000 | 7,201,000 | 1.38% | ||
| 29 | EDWARDS LIFESCIENCES CORP | 70,000 | 6,559,000 | 1.26% | ||
| 30 | NEVRO CORP | 89,314 | 6,490,000 | 1.24% | ||
| 31 | HOLOGIC INC | 160,000 | 6,419,000 | 1.23% | ||
| 32 | THERMO FISHER SCIENTIFIC INC | 45,000 | 6,350,000 | 1.22% | ||
| 33 | SUPERNUS PHARMACEUTICALS INC COM | 250,000 | 6,313,000 | 1.21% | ||
| 34 | XENCOR INC COM | 225,000 | 5,922,000 | 1.14% | ||
| 35 | JAZZ PHARMACEUTICALS PLC SHS USD | 50,920 | 5,552,000 | 1.06% | ||
| 36 | ZELTIQ AESTHETICS INCORPORATED | 125,000 | 5,440,000 | 1.04% | ||
| 37 | CENCORA | 68,000 | 5,317,000 | 1.02% | ||
| 38 | DEXCOM | 84,800 | 5,063,000 | 0.97% | ||
| 39 | ALNYLAM PHARMACEUTICALS INC | 135,000 | 5,054,000 | 0.97% | ||
| 40 | NEKTAR THERAPEUTICS COM | 410,000 | 5,031,000 | 0.96% | ||
| 41 | ENDO INTL | 300,200 | 4,944,000 | 0.95% | ||
| 42 | ARRAY BIOPHARMA INC COM | 550,000 | 4,835,000 | 0.93% | ||
| 43 | VERTEX PHARMACEUT | 65,013 | 4,790,000 | 0.92% | ||
| 44 | CARDINAL HEALTH INC | 65,000 | 4,678,000 | 0.90% | ||
| 45 | Lion Biotechnologies | 650,000 | 4,518,000 | 0.87% | ||
| 46 | INTRA CELLULAR THERAPIES INC COM | 290,000 | 4,376,000 | 0.84% | ||
| 47 | REVANCE THERAPEUTICS INC COM | 210,000 | 4,347,000 | 0.83% | ||
| 48 | ALKERMES PLC SHS | 75,599 | 4,202,000 | 0.81% | ||
| 49 | NXSTAGE MED INC COM | 158,901 | 4,165,000 | 0.80% | ||
| 50 | BIOMARIN | 50,000 | 4,142,000 | 0.79% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-17-000078, filed 2017.01.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
